Experienced in Lymphangioleiomyomatosis

Dr. Nirav Shah

Intensive Care Medicine
Office
110 S Paca St Fl 2, 
Baltimore, MD 
Experienced in Lymphangioleiomyomatosis
Office
110 S Paca St Fl 2, 
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Nirav Shah is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Lymphangioleiomyomatosis. His top areas of expertise are Interstitial Lung Disease, Neurosarcoidosis, Acute Interstitial Pneumonia, Sarcoidosis, and Gastrostomy.

His clinical research consists of participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Intensive Care Medicine
Licenses
Critical Care Medicine in MD
Hospital Affiliations
University Of Maryland Medical Center
University Of MD Medical Center Midtown Campus
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Office
110 S Paca St Fl 2, Baltimore, MD 21201
Call: 410-328-8141
Other Locations
University of Maryland Pediatric Associates PA
22 S Greene St, Baltimore, MD 21201
Call: 410-328-8141

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long Term Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis LUCENT 3
Enrollment Status: Active_not_recruiting
Publish Date: November 24, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: October 14, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
Prophylactic Topical Epinephrine to Reduce Transbronchial Lung Biopsy-related Hemorrhage in Lung Transplant Recipients: a Prospective Double-blind Placebo-controlled Trial (PROPHylactic Epinephrine in Transbronchial Biopsy [PROPHET] Trial)
Prophylactic Topical Epinephrine to Reduce Transbronchial Lung Biopsy-related Hemorrhage in Lung Transplant Recipients: a Prospective Double-blind Placebo-controlled Trial (PROPHylactic Epinephrine in Transbronchial Biopsy [PROPHET] Trial)
Enrollment Status: Completed
Publish Date: August 28, 2024
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 305)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Enrollment Status: Terminated
Publish Date: April 29, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
View 8 Less Clinical Trials
Similar Doctors
Experienced in Lymphangioleiomyomatosis
Dr. Janaki Deepak
Intensive Care Medicine
Experienced in Lymphangioleiomyomatosis
Dr. Janaki Deepak
Intensive Care Medicine

University Of Maryland Pediatric Associates PA

22 S Greene St, 
Baltimore, MD 
 (0.1 miles away)
410-328-2454
Languages Spoken:
English
See accepted insurances

Janaki Deepak is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Deepak is rated as an Advanced provider by MediFind in the treatment of Lymphangioleiomyomatosis. Her top areas of expertise are Neurosarcoidosis, Sarcoidosis, Interstitial Lung Disease, Lung Metastases, and Endoscopy.

Experienced in Lymphangioleiomyomatosis
Dr. Bo Kim
Intensive Care Medicine
Experienced in Lymphangioleiomyomatosis
Dr. Bo Kim
Intensive Care Medicine

Johns Hopkins Children's Center

1800 Orleans St, 
Baltimore, MD 
 (1.9 miles away)
410-955-4100
Languages Spoken:
English
See accepted insurances

Bo Kim is an Intensive Care Medicine provider in Baltimore, Maryland. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Lymphangioleiomyomatosis. His top areas of expertise are Cerebral Hypoxia, Acute Respiratory Distress Syndrome (ARDS), COVID-19, Lung Transplant, and Fasciotomy.

Experienced in Lymphangioleiomyomatosis
Dr. Ramin Pirouz
Intensive Care Medicine
Experienced in Lymphangioleiomyomatosis
Dr. Ramin Pirouz
Intensive Care Medicine

Calvert Internal Medicine Group PA

985 Prince Frederick Blvd Ste 201, 
Prince Frederick, MD 
 (52.9 miles away)
410-535-2005
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ramin Pirouz is an Intensive Care Medicine provider in Prince Frederick, Maryland. Dr. Pirouz has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Lymphangioleiomyomatosis. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Neurosarcoidosis, Gastrostomy, and Ureteroscopy.

VIEW MORE LYMPHANGIOLEIOMYOMATOSIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shah's expertise for a condition
ConditionClose
      • Advanced
      • Acute Interstitial Pneumonia
        Dr. Shah is
        Advanced
        . Learn about Acute Interstitial Pneumonia.
        See more Acute Interstitial Pneumonia experts
      • Interstitial Lung Disease
        Dr. Shah is
        Advanced
        . Learn about Interstitial Lung Disease.
        See more Interstitial Lung Disease experts
      • Lung Metastases
        Dr. Shah is
        Advanced
        . Learn about Lung Metastases.
        See more Lung Metastases experts
      • Neurosarcoidosis
        Dr. Shah is
        Advanced
        . Learn about Neurosarcoidosis.
        See more Neurosarcoidosis experts
      • Pneumonia
        Dr. Shah is
        Advanced
        . Learn about Pneumonia.
        See more Pneumonia experts
      • Sarcoidosis
        Dr. Shah is
        Advanced
        . Learn about Sarcoidosis.
        See more Sarcoidosis experts
      • Experienced
      • Allergic Bronchopulmonary Aspergillosis
        Dr. Shah is
        Experienced
        . Learn about Allergic Bronchopulmonary Aspergillosis.
        See more Allergic Bronchopulmonary Aspergillosis experts
      • Asthma
        Dr. Shah is
        Experienced
        . Learn about Asthma.
        See more Asthma experts
      • Asthma in Children
        Dr. Shah is
        Experienced
        . Learn about Asthma in Children.
        See more Asthma in Children experts
      • Atypical Pneumonia
        Dr. Shah is
        Experienced
        . Learn about Atypical Pneumonia.
        See more Atypical Pneumonia experts
      • Bronchiectasis
        Dr. Shah is
        Experienced
        . Learn about Bronchiectasis.
        See more Bronchiectasis experts
      • Bullae
        Dr. Shah is
        Experienced
        . Learn about Bullae.
        See more Bullae experts
      View All 24 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.